International Cancer Cluster Showcase
  • Home
  • Agenda
  • Presenting Companies
    • Presenting Companies 2023
    • Presenting Companies 2022
    • Presenting Companies 2021
    • Presenting Companies 2020
  • Sponsors
    • Sponsors 2023
    • Sponsors 2020
    • Sponsors 2021
  • Organizers & Contacts
  • Archive
    • ICCS 2023
    • ICCS 2022
    • ICCS 2021
    • ICCS 2020
    • ICCS 2019
    • ICCS 2018
    • ICCS 2017
    • ICCS 2016
    • ICCS 2015
    • ICCS 2014
    • ICCS 2013
    • ICCS 2012

 International Cancer Cluster Showcase goes ATMP
Monday June 16th, 2025
@ Foley Hoag, Seaport West, 155 Seaport Boulevard, Boston 

(10 min walk to the Boston Convention Center)

Download PDF of the FINAL AGENDA incl. the right order of the presenting companies!


09:30 - 10:00 AM     Registration & Coffee

10:00 - 10:10 AM      
Welcome by Abi Barrow, Cambridge Innovation Partners for the ICCS Organizing Partners. 
Opening Remarks by Bernd Mühlenweg, SVP, Head of Global BD, Cell Therapy Evotec "From Breakthroughs to Business Models: The Cell Therapy Landscape in Transition"

10:10 - 11:00 AM      Expert Panel: From Discovery to Delivery - A Call for Transformative Partnerships
                                Moderated by Jutta Heix, Head of International Affairs, Oslo Cancer Cluster.


Speakers:
​

●​ Marcela Maus, Director Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Professor of Medicine, Harvard Medical School

●​ Michael Birnbaum, Associate Professor of biological engineering, MIT; Team Lead MATCHMAKERS Consortium
​

● Fiona Mack, VP, Head of Bayer Co.Lab Cambridge

● Jason Bock, Co-Founder and CEO CTMC


11:00 - 12:00 PM     Cell Therapy Innovators: Showcase & Feedback Session

12 start-ups from European, US and Asian innovation hubs give 3,5 min pitches complemented by 1,5 min feedback per company. Plus: opportunity for more detailed feedback and discussions during the Networking Lunch.

Pan Cancer T (NL); Anocca (SWE); T-Knife (GER); InnDura (US); Strike Pharma (SWE); Chimeron Bio (US); AlterBio (US); iXgene (Japan); TILT Biotherapeutics (FIN); Monarch Therapeutics (US); ImmunoKey (UK) and Limula (Switzerland)


12:00 - 12:05 PM      Closing by Harpreet Singh, CMO Precision for Medicine: "Charting the Future: CGT Regulation in Europe and the US"
​Wrap up by ICCS Organizing Partners

12:05 - 12:30 PM
      Mingling & Light lunch


This event is kindly supported by;

Picture
Picture
Picture
Picture

ICCS Agenda 2023

ICCS Agenda 2022
​

ICCS Agenda 2021


Proudly powered by Weebly